NO20013039D0 - Apparat og fremgangsmåte for fremstilling av krystallinske partikler - Google Patents

Apparat og fremgangsmåte for fremstilling av krystallinske partikler

Info

Publication number
NO20013039D0
NO20013039D0 NO20013039A NO20013039A NO20013039D0 NO 20013039 D0 NO20013039 D0 NO 20013039D0 NO 20013039 A NO20013039 A NO 20013039A NO 20013039 A NO20013039 A NO 20013039A NO 20013039 D0 NO20013039 D0 NO 20013039D0
Authority
NO
Norway
Prior art keywords
preparation
crystalline particles
crystalline
particles
Prior art date
Application number
NO20013039A
Other languages
English (en)
Other versions
NO20013039L (no
Inventor
Robert William Lancaster
Hardev Singh
Andrew Lewis Theophilus
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20013039D0 publication Critical patent/NO20013039D0/no
Publication of NO20013039L publication Critical patent/NO20013039L/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B01D9/0054—Use of anti-solvent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0059—General arrangements of crystallisation plant, e.g. flow sheets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/41—Emulsifying
    • B01F23/411—Emulsifying using electrical or magnetic fields, heat or vibrations
    • B01F23/4111—Emulsifying using electrical or magnetic fields, heat or vibrations using vibrations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/80—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations
    • B01F31/85—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations with a vibrating element inside the receptacle
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/45—Magnetic mixers; Mixers with magnetically driven stirrers
    • B01F33/452—Magnetic mixers; Mixers with magnetically driven stirrers using independent floating stirring elements
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
    • B01J19/10—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing sonic or ultrasonic vibrations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/18—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic using a vibrating apparatus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nozzles (AREA)
  • Steroid Compounds (AREA)
NO20013039A 1998-12-24 2001-06-19 Apparat og fremgangsmate for fremstilling av krystallinske partikler NO20013039L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9828721.2A GB9828721D0 (en) 1998-12-24 1998-12-24 Novel apparatus and process
PCT/GB1999/004368 WO2000038811A1 (en) 1998-12-24 1999-12-22 Apparatus and process for preparing crystalline particles

Publications (2)

Publication Number Publication Date
NO20013039D0 true NO20013039D0 (no) 2001-06-19
NO20013039L NO20013039L (no) 2001-08-22

Family

ID=10845091

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013039A NO20013039L (no) 1998-12-24 2001-06-19 Apparat og fremgangsmate for fremstilling av krystallinske partikler

Country Status (19)

Country Link
US (1) US6482438B1 (no)
EP (1) EP1144065A1 (no)
JP (1) JP3588050B2 (no)
KR (1) KR20010099933A (no)
CN (1) CN1335787A (no)
AU (1) AU759880B2 (no)
BR (1) BR9916587A (no)
CA (1) CA2356897A1 (no)
CZ (1) CZ20012331A3 (no)
GB (1) GB9828721D0 (no)
HK (1) HK1038709A1 (no)
HU (1) HUP0104855A3 (no)
IL (1) IL143811A (no)
NO (1) NO20013039L (no)
NZ (1) NZ512400A (no)
PL (1) PL349345A1 (no)
TR (1) TR200101845T2 (no)
WO (1) WO2000038811A1 (no)
ZA (1) ZA200105070B (no)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8123130B2 (en) 1998-04-17 2012-02-28 Remote Inc. Remote ordering device
JP2002541183A (ja) 1999-04-14 2002-12-03 グラクソ グループ リミテッド 医薬用エアゾール製剤
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0016002D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
DZ3468A1 (fr) 2000-08-05 2002-02-14 Glaxo Group Ltd 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyle) oxy!-11.beta.-hydroxy-16.alpha.-methyle-3-oxo-androst-1,4,-diene-17-acide carbothioique s-fluoromethyle ester utilise comme agent anti inflammatoire
FI20002215A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
CN1302007C (zh) 2001-04-30 2007-02-28 葛兰素集团有限公司 具有抗炎性的在17.α位上具有环酯基的雄甾烷的17.β.－硫代羧酸酯衍生物
NZ529258A (en) * 2001-05-05 2004-07-30 Accentus Plc Formation of small crystals
DE10137017A1 (de) * 2001-07-30 2003-02-20 Basf Ag Kristallisationsverfahren zur Einstellung kleiner Partikel
CA2458889C (en) * 2001-08-29 2011-06-21 Dow Global Technologies Inc. A process for preparing crystalline drug particles by means of precipitation
GB0125604D0 (en) * 2001-10-25 2001-12-19 Glaxo Group Ltd Novel process
GB0201400D0 (en) 2002-01-22 2002-03-13 Glaxo Group Ltd Novel apparatus and process
US20040005256A1 (en) * 2002-04-29 2004-01-08 Chenkou Wei Crystallization system utilizing atomization
GB0219815D0 (en) * 2002-08-24 2002-10-02 Accentus Plc Preparation of small crystals
GB0212626D0 (en) * 2002-05-31 2002-07-10 Accentus Plc Production of crystalline ingredients
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
US20040197275A1 (en) 2002-10-17 2004-10-07 Ecole Polytechnique Federale De Lausanne Process for the manufacture of powders of inhalable medicaments
CA2502502C (en) * 2002-10-17 2013-06-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the manufacture of powders of inhalable medicaments
GB0302673D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
US20070065372A1 (en) * 2003-02-21 2007-03-22 Robert Price Process for the production of particles
CN100404545C (zh) * 2003-03-27 2008-07-23 尼科梅德有限责任公司 具有规定粒径的结晶环缩松的制备方法
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
WO2004087243A1 (ja) 2003-03-27 2004-10-14 Bioactis Limited 鼻腔用粉末薬剤施薬装置
SE0302029D0 (sv) * 2003-07-07 2003-07-07 Astrazeneca Ab Novel process
ITMI20032054A1 (it) * 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
JP2005177746A (ja) * 2003-11-28 2005-07-07 Mitsubishi Chemicals Corp 有機化合物微粒子の製造方法
WO2005051511A1 (ja) * 2003-11-28 2005-06-09 Mitsubishi Chemical Corporation 有機化合物微粒子の製造方法
WO2006016530A1 (ja) 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
EP1949891A1 (en) * 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
EP1811981B1 (en) * 2004-10-12 2008-08-13 Merck Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
US7314516B2 (en) * 2004-12-29 2008-01-01 Five Star Technologies, Inc. Hydrodynamic cavitation crystallization device and process
NZ556709A (en) 2005-02-10 2009-09-25 Glaxo Group Ltd Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
US20090186088A1 (en) * 2005-03-18 2009-07-23 Nanomaterials Technology Pte Ltd Inhalable drug
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
WO2006113309A1 (en) 2005-04-15 2006-10-26 Dr. Reddy's Laboratories Ltd. Lacidipine particles
DE102005053862A1 (de) * 2005-11-04 2007-05-10 Pharmasol Gmbh Verfahren und Vorrichtung zur Herstellung hochfeiner Partikel sowie zur Beschichtung solcher Partikel
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
GB0610090D0 (en) * 2006-05-20 2006-06-28 Price Robert Particulate drug compositions and their uses
US7811381B2 (en) * 2006-06-14 2010-10-12 Sirkar Kamalesh K Antisolvent crystallization in porous hollow fiber devices and methods of use thereof
CA2654644C (en) * 2006-06-14 2014-02-18 Generics [Uk] Limited Novel process and intermediates
AU2013202835B2 (en) * 2006-06-14 2015-11-12 Generics [Uk] Limited Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1, 4-diene-17-carbothioate and intermediates
EP2116264B1 (en) 2006-12-26 2017-09-27 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
JP2010111592A (ja) * 2008-11-04 2010-05-20 Aska Pharmaceutical Co Ltd プロピオン酸フルチカゾンを含む局所投与剤
GB0900080D0 (en) * 2009-01-06 2009-02-11 Prosonix Ltd An apparatus and process for producing crystals
DE102009008478A1 (de) 2009-02-11 2010-08-19 PHAST Gesellschaft für pharmazeutische Qualitätsstandards mbH Vorrichtung und Verfahren zur Herstellung pharmazeutisch hochfeiner Partikel sowie zur Beschichtung solcher Partikel in Mikroreaktoren
JP2012526726A (ja) 2009-05-15 2012-11-01 株式会社新日本科学 薬物動態が改善された鼻腔内用薬学的組成物
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
CA3023725C (en) 2009-10-22 2021-09-14 Vizuri Health Sciences Llc Methods of producing hydrated flavonoids and use thereof in the preparation of topical compositions
KR101823706B1 (ko) 2010-03-22 2018-01-30 인스틸로 게엠베하 마이크로입자 또는 나노입자의 제조 방법 및 제조 장치
CN101862633B (zh) * 2010-07-10 2012-07-11 浙江卫信生物药业有限公司 全自动无菌恒温连续流体制剂超声波匀化处理装置
US9278867B2 (en) 2010-12-30 2016-03-08 Yava Technologies Inc. Transition metal compound particles and methods of production
EP2500072A1 (en) * 2011-03-15 2012-09-19 LEK Pharmaceuticals d.d. A novel process of residual solvent removal
KR20200117056A (ko) * 2011-07-08 2020-10-13 화이자 리미티드 플루티카손 프로피오네이트 형태 1의 제조 방법
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
PL3517541T3 (pl) * 2012-05-08 2020-12-28 Nicox Ophthalmics, Inc. Postać polimorficzna propionianu flutykazonu
DE102012221219B4 (de) * 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US9452930B2 (en) * 2013-11-04 2016-09-27 New Jersey Institute Of Technology System and method for continuous polymer coating of particles
CN103977593B (zh) * 2014-05-19 2017-01-04 中国工程物理研究院化工材料研究所 制备纳米共晶含能材料的方法及装置
CN105012237B (zh) * 2015-08-10 2018-09-11 重庆华邦制药有限公司 糠酸氟替卡松鼻喷雾剂及其制备方法
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN109012260B (zh) * 2018-09-06 2020-10-02 董旭 一种便于配比的麻醉药物混合器
WO2020205539A1 (en) 2019-03-29 2020-10-08 Vizuri Health Sciences Consumer Healthcare, Inc. Compositions and methods for the prevention and treatment of radiation dermatitis, eczema, burns, wounds and certain cancers

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL67349C (no) * 1946-01-16
DE1262240B (de) 1964-11-14 1968-03-07 Helmut Pelzer Dipl Chem Dr Verfahren zur Herstellung feinster Teilchen kristallisierbarer Verbindungen
DE2504347C3 (de) * 1975-02-03 1978-10-05 Dso, Pharmachim, Sofia Verfahren zur Herstellung von reinem Tetracyclinhydrochlorid
US3979269A (en) 1975-02-25 1976-09-07 DSO "Pharmachim Method for obtaining tetracyclinehydrochloride
HU209603B (en) * 1988-10-05 1994-09-28 Upjohn Co Process for production of solid powders in finalydivided microcristallin form
JPH02164712A (ja) 1988-12-17 1990-06-25 Tosoh Corp 重炭酸ナトリウムの製造方法
GB9005275D0 (en) 1990-03-09 1990-05-02 Atomic Energy Authority Uk Crystallization monitor
JPH0497908A (ja) 1990-08-10 1992-03-30 Lion Corp ゼオライトの製造方法
AU5171293A (en) 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery
GB9307225D0 (en) 1993-04-03 1993-05-26 Atomic Energy Authority Uk Processing vessel
US5471001A (en) * 1994-12-15 1995-11-28 E. I. Du Pont De Nemours And Company Crystallization of adipic acid
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
US5905003A (en) 1995-06-26 1999-05-18 Energy Conversion Devices, Inc. Beta to gamma phase cycleable electrochemically active nickel hydroxide material
GB9624615D0 (en) 1996-11-26 1997-01-15 Zeneca Ltd Chrystallisation process
IL130715A (en) * 1997-02-05 2003-07-31 Merck & Co Inc Form i of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoro-methyl-1,4-dihydro-2h-3,1-benzoxazin-2-one and a process for preparing the crystalline form of said compound
GB9826175D0 (en) 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826242D0 (en) 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
CN1182903C (zh) 1999-01-29 2005-01-05 布里斯托尔-迈尔斯斯奎布公司 声波冲击喷射结晶设备和工艺

Also Published As

Publication number Publication date
GB9828721D0 (en) 1999-02-17
HUP0104855A3 (en) 2005-12-28
AU759880B2 (en) 2003-05-01
CZ20012331A3 (cs) 2002-03-13
EP1144065A1 (en) 2001-10-17
ZA200105070B (en) 2002-09-20
WO2000038811A1 (en) 2000-07-06
NO20013039L (no) 2001-08-22
US6482438B1 (en) 2002-11-19
IL143811A0 (en) 2002-04-21
HUP0104855A2 (hu) 2002-04-29
JP2002533205A (ja) 2002-10-08
CN1335787A (zh) 2002-02-13
KR20010099933A (ko) 2001-11-09
IL143811A (en) 2005-06-19
HK1038709A1 (zh) 2002-03-28
NZ512400A (en) 2003-02-28
JP3588050B2 (ja) 2004-11-10
BR9916587A (pt) 2001-09-25
CA2356897A1 (en) 2000-07-06
AU1877100A (en) 2000-07-31
TR200101845T2 (tr) 2001-10-22
PL349345A1 (en) 2002-07-15

Similar Documents

Publication Publication Date Title
NO20013039L (no) Apparat og fremgangsmate for fremstilling av krystallinske partikler
HUP0203278A3 (en) Apparatus and process for preparing crystalline particles
HUP0201482A2 (en) Method and apparatus for the manufacture of meat
NO984161D0 (no) Fremgangsmåte og innretning for fremstilling av etalisk jern
NO20015239L (no) Fremgangsmåte og apparat for å produsere uniforme små porsjoner av fine pulvere og produkter av disse
IL139926A0 (en) Method and associated apparatus for the standardized grading of gemstones
AU6530900A (en) Method and apparatus for the digital creation of fur effects
HU9900991D0 (en) Method and apparatus for the partial melting of articles
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20001999D0 (no) Fremgangsmõte for fremstilling av polymermaterialer med heterofase og slike materialer
HUP9801844A3 (en) New crystalline form of n-(4-trifluormethylphenyl)-5-methyl-isoxazole-4-carboxamid and process for the preparation thereof
DK1034396T3 (da) Fremgangsmåde og apparat til afskibning af superfrosne materialer
EP1122342A4 (en) PROCESS FOR REMOVING DEFECTS FROM CRYSTAL MATERIAL AND CRYSTAL MATERIAL
NO973937D0 (no) Fremgangsmåte og anordning for fremstilling av börstevarer og börstevarer fremstilt med disse
AU3180800A (en) Method and apparatus for the analysis of material composition
NO994505D0 (no) Forbedret fremgangsmÕte for fremstilling av tiazolidindioner og nye tiazolidindioner
DE69934550D1 (de) Verfahrenskassette und elektrophotographischer Apparat
NO952705D0 (no) Fremgangsmåte og innretning for fiske av flatfiske og liknende
NO942209L (no) Fremgangsmåte og apparat for ekspansjon av tobakk
GB2287684B (en) Method and apparatus for turning ceramic ware
EP0724028A3 (en) Process for producing wire-like silicon a crystal
NO980794D0 (no) Fremgangsmåte og apparat for produksjon av betong-elementer
IL131283A0 (en) Apparatus and methods for inspection of objects
NO961871L (no) Apparat og fremgangsmåte for fremstilling av flerforpakninger
HU9900992D0 (en) Method and apparatus for the production of plasma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application